Normal tissue sparing in a phase II trial on daily adaptive plan selection in radiotherapy for urinary bladder cancer

Abstract

Daily adaptive plan selection in RT of bladder cancer results in a considerable normal tissue sparing, of a magnitude that we expect will translate into a clinically significant reduction of the treatment-related morbidity.